CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,029 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,930 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,175 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,930 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,404 shares (to pay taxes)
- 4 Open-market sale Director and CEO, Alkermes plc sold 150,000 shares at $21.90 ($3,285,405)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 50,000 shares at $22.09 ($1,104,650)
- 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 2,250 shares at $22.23 ($50,018)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $22.39 ($559,695)
- 4 Open-market sale Director and CEO, Alkermes plc sold 150,000 shares at an average $22.09 ($3,313,339)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 19,477 shares at $22.10 ($430,522)
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $21.79 ($2,179,410)
- 4 Open-market sale EVP, Chief Operating Officer sold 34,503 shares at $22.18 ($765,156)
- 4 Open-market sale Director sold 25,000 shares at $20.00 ($500,120)
Page 17 of 67 · 1,323 filings